FierceHealthcareFierceHealthITFierceHealthFinanceFierceEMRHospital ImpactFierceMobileHealthcare   FiercePharma

SPOTLIGHT: Terminal patients not entitled to unapproved drugs

Tools
Tags
Food and Drug Administration (FDA)
FDA approval


The Supreme Court has ruled that terminally ill patients have no constitutional right to gain access to experimental drugs which haven't yet won FDA approval. Advocates had argued that the FDA was violating the legal rights of patients by making them wait until companies complete long clinical trials. Article

Bookmark and Share
Get Your FREE FierceHealthcare Email Newsletter:
Be the first to comment

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

To combat spam, please enter the code in the image.